
Is There an Optimal Biological Dose?
Challenges in Phase I
November 07, 2012 | Length: 20:48 min
Further Lectures


Innate and adaptive immunity regulated within the tumor microenvironment
Microenvironment

Targeting Tumour-Stroma Interaction for Prevention of Metastasis
Microenvironment

Prostate Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC): a Phase 1 Trial in Castration-Resistant Metastatic Prostate Cancer (mCRPC)
Proffered Paper Session
Infos
Congress: | 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
---|---|
Presenter: | L. Siu |
Category: | Cancer; Clinical Trials; |